Demant announces that Arne Boye Nielsen, President of Diagnostics and Communications, and Niels Wagner, President of Hearing Care, will join the Executive Board effective April 1, 2022, which means that the Executive Board will consist of four members going forward.
Over the last years, Demant has seen “a substantial increase in activities across its different business areas, and the company has generated consistent and profitable growth, which has only been disrupted by the unforeseen IT incident and the pandemic,” according to the company’s announcement. Nielsen and Wagner have been instrumental in the Group’s growth journey and in the overall development of the Demant Group, and their respective business areas have, especially during the last decade, increased significantly and gained market shares, Demant says. The company reports that, as a natural consequence of the Group’s development, the Board of Directors has therefore decided to appoint them members of the Executive Board.
Nielsen has been employed with Demant for over 30 years and has been President of Diagnostics since 1996. Wagner has been with Demant since 1996, however with a few years with other companies, and has been President of Hearing Care since 2015. For more than 10 years, they have both been part of the Demant management team, which also consists of Søren Nielsen, President & CEO, and René Schneider, CFO.
“The addition of Arne and Niels to the Executive Board reflects the successful development of the Demant Group, and I am confident that the extended leadership team have the capabilities and experience to continue our remarkable journey towards becoming the world’s leading hearing healthcare company,” said Niels B. Christiansen, Chairman of the Board of Directors of Demant.
“I am very excited to have Arne and Niels join the Executive Board. Both have been valued and trusted colleagues for the past many years and during a period where the company has developed immensely. Arne and Niels’ contributions as leaders have been vital in developing Demant towards becoming the company that we see today, and I look forward to continuing our close collaboration in the future where we will continue to execute on our ambitious strategy and plans,” said Søren Nielsen, President & CEO of Demant.
Following the appointments, the Executive Board now consists of Søren Nielsen, President & CEO; René Schneider, CFO; Arne Boye Nielsen, President, Diagnostics and Communications; and Niels Wagner, President, Hearing Care.